Summary of "Routes of Drugs Administration (Part II)"
Main ideas / lesson conveyed
The speaker continues a pharmacy-focused discussion on routes of drug administration, explaining that “routes” refers to the portal of entry and pathway by which a drug is introduced into the body.
Routes are organized into major categories, including:
- Enteral (GI) vs parenteral (injection)
- Mucosal routes
- Transdermal/skin routes
- Other local routes
For each route, the talk highlights:
- Typical advantages
- Key limitations/challenges
- Common examples
Outline of concepts and instructions (teaching guide)
1) Core classification of administration routes
Enteral (GI tract)
- Drugs introduced through the gastrointestinal (GI) tract.
Parenteral (non-GI routes)
- Usually refers to injections/injectables (via needles), meaning routes other than GI.
2) Enteral / GI-related routes
A) Sublingual / Buccal (in mouth)
What it is
- Sublingual: dosage form placed under the tongue
- Buccal: dosage form retained in the buccal cavity
Advantages
- Rapid absorption
- The mouth area is highly vascularized, allowing fast uptake.
- Improved drug stability
- Avoids harsher stomach acid/enzyme conditions.
- Avoids first-pass metabolism (first-pass effect)
- Initially reaches systemic circulation before liver metabolism.
Limitations / when NOT suitable
- Inconvenience/discomfort
- Patient may not tolerate placement in the mouth.
- Dose-size limitation
- Best for small-dose drugs.
- Not suitable for high-dose drugs (e.g., paracetamol up to ~500 mg, even 1 g is mentioned as too high).
- Taste issues
- Not suitable for drugs with bitter/unpleasant taste, which can cause nausea.
B) Oral (swallowed; “per os”)
What it is
- Dosage form is ingested, moving through the GI tract (stomach → intestine).
Advantages
- Most convenient
- Tablets, capsules, syrups, suspensions, etc.
- Longer contact time
- Drug remains in stomach and intestine long enough to support absorption.
- Often cheap and generally safe
- Compared with many alternatives (e.g., injectables/inhalation).
- Manageable overdose
- Example implied: gastric lavage.
- Contrast: harder once drug is already in blood (e.g., IV).
Limitations / challenges
- Hard to control absorption precisely
- Bioavailability depends on:
- GI conditions
- pH
- gastric emptying rate
- presence of food/drinks
- disease states
- nausea/vomiting/diarrhea
- Bioavailability depends on:
- First-pass effect
- Oral drugs go through portal circulation → liver.
- Examples mentioned:
- Propranolol
- Aspirin undergoes extensive first-pass metabolism.
C) Rectal (suppositories; last part of GI tract)
What it is / purpose
- Targets local and/or systemic effects.
- Rationale:
- Avoids stomach harsh environment (acid/enzymes).
- Can support systemic absorption and evade first-pass metabolism.
Common uses (local effects)
- Hemorrhoids
- anti-inflammatory drugs
- vasoconstricting drugs
- Constipation
- stimulants to promote bowel movement
Advantages
- Can provide local relief, and sometimes systemic effect.
- Useful when oral route is unsuitable:
- infants/young children
- elderly patients
- patients with vomiting
Limitations / challenges
- Erratic and incomplete absorption
- Amount reaching circulation is unpredictable.
- The talk implies best-case completion may be around ~70–80% (with higher being less reliable).
- Risk of rectal irritation
- Cultural acceptability issues
- Some cultures may find rectal use offensive or unacceptable.
3) Parenteral routes (injections / injectables)
General advantages of parenteral
- Rapid onset
- Bypasses first-pass metabolism and GI hostile conditions
- More accurate dosing
- Especially IV, where dose goes directly into circulation
- Less GI irritation
- Useful for drugs that irritate the GI tract
General challenges
- Pain
- Infection risk
- Requires sterile technique/sterile needle and formulation
- Toxicity handling is difficult
- Once injected, removal is hard
- Often more expensive
- Sterility requirements increase cost
- Formulation constraints
- Often must be isotonic to blood (unless noted)
- Exception mentioned: intramuscular may sometimes use slightly hypertonic solutions to enhance absorption
The “main four” parenteral injection routes
- Intravenous (IV) → into vein
- Intramuscular (IM) → into muscle
- Subcutaneous (SC) → into subcutaneous tissue
- Intradermal (ID) → into dermis of skin
A) Intravenous (IV)
Advantages
- Very rapid onset
- Effects may begin within seconds.
- 100% bioavailability
- Entire dose delivered directly into blood.
- Accurate dosing
- Can deliver:
- small volumes as injections
- large volumes as infusions
- Maintains constant drug level
- Useful in hospital settings to stay within the therapeutic index.
Limitations / challenges
- Severe reaction risk
- e.g., anaphylaxis/hypersensitivity
- typically given in controlled hospital settings
- Thrombophlebitis
- vein inflammation from solution leakage around the vein
- Solubility requirement
- Typically needs water-soluble solutions
- Not suited for suspensions (as stated)
B) Intramuscular (IM)
Advantages
- Faster than oral/enteral; slower than IV
- Allows suspensions and oil-based preparations
- Used to control duration:
- slower onset
- extended duration (may last weeks/months)
- Used to control duration:
- Example mentioned:
- long-acting penicillin antibiotics to reduce painful daily injections
Limitations / challenges
- Limited injection volume
- often ~3–5 mL, sometimes up to 10 mL
- larger volumes raise pain/inflammation risk
C) Subcutaneous (SC)
Advantages
- Can often be self-administered
- example: diabetes
- Supports controlled release via:
- solutions or suspensions
- Common examples mentioned:
- insulin
- heparin
- adrenaline (also possible)
Limitations / challenges
- Slower than IV and IM
- Small volume limit
- about 1–2 mL
- Larger volumes under the skin increase discomfort and risk
D) Intradermal (ID)
What it is
- Injection into dermis.
- Mostly used for vaccines and tests.
Uses
- Immune tests
- TB testing example (tuberculin-like skin reaction; positive suggests exposure)
- Allergy testing
- inject allergens and observe reaction
Limitations
- Must be very small volumes
- stated as < ~0.1–0.2 mL
Other parenteral routes (briefly mentioned)
- Intraperitoneal (into peritoneal cavity)
- Intrathecal (into spinal/near CNS space)
- Intra-articular (into joints)
- Intracardiac (directly into heart; referenced via a movie scene)
- Intra-arterial (directly into arteries; less common)
4) Mucosal routes
Focus: targeting mucosal surfaces for local (and sometimes systemic) effects.
A) Pulmonary (inhalation; lungs/bronchi)
Advantages
- Suitable when disease is located in lungs/bronchi (e.g., asthma)
- Local effect predominates
- Rapid onset (minutes)
Limitations / challenges
- Patient technique training required
- must synchronize inhalation with device actuation
- poor technique may cause dose to end in the stomach instead of lungs
- Cost
- inhalation products may be more expensive than tablets/capsules
- Mouth/throat irritation
- Requires patient counseling
B) Ophthalmic (eye)
Uses
- Local treatment for:
- inflammation/irritation
- allergy
- Example mentioned related to pupil effects (glaucoma context):
- agents that dilate vs constrict the pupil
Dosage forms
- Drops
- Ointments/ointments (and other forms mentioned)
- suspensions require attention to particle size (too large → irritation)
Advantages
- Direct targeting of eye conditions (mostly local effects)
Limitations / challenges
- Very short contact time
- blinking and tears wash drugs away quickly
- Need formulation strategies to increase contact time:
- increased viscosity with excipients
- gel-like/ointment strategies
- Sterility required
- infection risk is critical
- Isotonicity required to prevent irritation
C) Nasal
Advantages
- Less hostile than GI (no extreme stomach pH)
- Local and systemic effects
- Decongestants for nasal congestion
- Systemic absorption possible via nasal mucosa
- examples mentioned:
- calcitonin for osteoporosis
- interest in nasal insulin
- examples mentioned:
- Possible CNS effect for certain drugs
Limitations / challenges
- Very limited contact time
- washed away
- Enzymatic degradation affects drug stability
- Nasal irritation risk
- Not practical for all drug types
- Tends to fit small-dose drugs better
D) Vaginal
Advantages
- Local and systemic effects possible
- Avoids first-pass metabolism (as stated)
- Local irritation and degradation can occur, but route remains useful
Dosage forms/shapes
- Vaginal suppositories
- colic/pessaries
- tablets, solutions, creams
Common uses
- antiseptics/antifungal treatment
- hormones (local or absorbed systemically)
- prostaglandins (systemic absorption possible)
Limitations / challenges
- Local irritation
- Lower pH environment (lactic acid) may degrade some drugs
- Cultural acceptability issues in some places
5) Skin-related routes
A) Topical (local) vs Transdermal (systemic)
Topical/local
- Drug acts at the skin surface or nearby.
- Examples mentioned:
- insect repellents
- catalytic/keratolytic-type “peeling” agents (salicylic acids mentioned)
- anti-itch treatments
- cosmetic uses (moisturizers, anti-aging)
Transdermal / percutaneous (systemic delivery)
- Drug penetrates through skin (especially the stratum corneum) to reach blood.
- Often delivered via patches.
Advantages
- Avoids first-pass metabolism
- Provides constant controlled release
- patch can maintain drug levels over time (days up to a week)
- Easy termination
- remove patch to stop absorption
- Absorption enhancement methods mentioned:
- low-voltage electricity
- ultrasound
- heat
- microneedles
- vesicles/other delivery technologies
Limitations / challenges
- Typically effective only for low-dose/small molecular drugs
- nicotine patch given as the most famous example
- Patient factors affect absorption:
- infant skin (immature) → overdose/toxicity risk
- elderly skin (dry) → reduced absorption
- hair presence; shaving can damage stratum corneum
- site of application matters (behind ears vs hands/soles thickness)
- patch adhesive can irritate skin
- Limited drug list:
- nicotine, some hormones (testosterone/estrogens mentioned), scopolamine for motion sickness
- Transdermal delivery can be expensive
6) Ear route (otic) (briefly mentioned)
- Mainly targets local effects.
- Uses:
- antiseptics and local antibiotics
- Also solvent-type softeners for excess ear wax (“wax softeners” mentioned)
Speakers / sources featured
- Ellen (name appears in subtitles: “Oh Ellen … in this session …”)
- The course instructor/speaker (not clearly named in the subtitles; teaching pharmacy “routes of drug administration”)
Category
Educational
Share this summary
Is the summary off?
If you think the summary is inaccurate, you can reprocess it with the latest model.
Preparing reprocess...